GlassScriptPhysician profile
Joseph N Ranieri
NPI 1851464143
$27,996.74
in general payments reported to CMS, 2019-2025
7 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
See the full distribution for Addiction Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,426 · 2020: $3,662 · 2021: $7,890 · 2022: $6,580 · 2023: $17.00 · 2024: $236 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $27,450.05 | 2019-2025 | Vivitrol, Vivitrol |
| Braeburn INC. | $213.63 | 2024-2025 | Brixadi |
| Mdd US Operations, LLC | $164.83 | 2019-2020 | |
| Uswm, LLC | $77.16 | 2021-2022 | |
| Gilead Sciences, INC. | $47.26 | 2024 | |
| Bioxcel Therapeutics, INC. | $23.07 | 2024 | Igalmi |
| Indivior INC. | $20.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ranieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.